.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
US Army
Cerilliant
Deloitte
Novartis
Accenture
AstraZeneca
Citi
Moodys
Dow

Generated: July 21, 2017

DrugPatentWatch Database Preview

DIAMOX Drug Profile

« Back to Dashboard

What is the patent landscape for Diamox, and when can generic versions of Diamox launch?

Diamox is a drug marketed by Teva Branded Pharm and Teva Womens and is included in three NDAs.

The generic ingredient in DIAMOX is acetazolamide sodium. There are ten drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the acetazolamide sodium profile page.

Summary for Tradename: DIAMOX

Patents:0
Applicants:2
NDAs:3
Suppliers / Packagers: see list2
Bulk Api Vendors: see list63
Clinical Trials: see list13
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DIAMOX at DailyMed

Pharmacology for Tradename: DIAMOX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Branded Pharm
DIAMOX
acetazolamide
TABLET;ORAL008943-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
Teva Womens
DIAMOX
acetazolamide sodium
INJECTABLE;INJECTION009388-001Dec 5, 1990DISCNYesNo► Subscribe► Subscribe
Teva Branded Pharm
DIAMOX
acetazolamide
TABLET;ORAL008943-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
Teva Branded Pharm
DIAMOX
acetazolamide
CAPSULE, EXTENDED RELEASE;ORAL012945-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Teva
Federal Trade Commission
McKesson
Chinese Patent Office
US Department of Justice
Harvard Business School
Medtronic
Covington
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot